Cargando…

Biosimilar, biobetter and next generation therapeutic antibodies

Detalles Bibliográficos
Formato: Texto
Lenguaje:English
Publicado: Landes Bioscience 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3092613/
https://www.ncbi.nlm.nih.gov/pubmed/21285536
http://dx.doi.org/10.4161/mabs.3.2.14785
_version_ 1782203389920149504
collection PubMed
description
format Text
id pubmed-3092613
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Landes Bioscience
record_format MEDLINE/PubMed
spelling pubmed-30926132012-03-01 Biosimilar, biobetter and next generation therapeutic antibodies MAbs Editorial Landes Bioscience 2011 2011-03-01 /pmc/articles/PMC3092613/ /pubmed/21285536 http://dx.doi.org/10.4161/mabs.3.2.14785 Text en Copyright © 2011 Landes Bioscience Open Access
spellingShingle Editorial
Biosimilar, biobetter and next generation therapeutic antibodies
title Biosimilar, biobetter and next generation therapeutic antibodies
title_full Biosimilar, biobetter and next generation therapeutic antibodies
title_fullStr Biosimilar, biobetter and next generation therapeutic antibodies
title_full_unstemmed Biosimilar, biobetter and next generation therapeutic antibodies
title_short Biosimilar, biobetter and next generation therapeutic antibodies
title_sort biosimilar, biobetter and next generation therapeutic antibodies
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3092613/
https://www.ncbi.nlm.nih.gov/pubmed/21285536
http://dx.doi.org/10.4161/mabs.3.2.14785